HomeCompareDSKYF vs KO

DSKYF vs KO: Dividend Comparison 2026

DSKYF yields 2.50% · KO yields 2.70%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DSKYF wins by $175.55M in total portfolio value
10 years
DSKYF
DSKYF
● Live price
2.50%
Share price
$18.42
Annual div
$0.46
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$175.59M
Annual income
$163,081,726.45
Full DSKYF calculator →
KO
The Coca-Cola Company
● Live price
2.70%
Share price
$76.27
Annual div
$2.06
5Y div CAGR
24.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.1K
Annual income
$4,303.79
Full KO calculator →

Portfolio growth — DSKYF vs KO

📍 DSKYF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDSKYFKO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DSKYF + KO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DSKYF pays
KO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DSKYF
Annual income on $10K today (after 15% tax)
$212.91/yr
After 10yr DRIP, annual income (after tax)
$138,619,467.48/yr
KO
Annual income on $10K today (after 15% tax)
$229.58/yr
After 10yr DRIP, annual income (after tax)
$3,658.22/yr
At 15% tax rate, DSKYF beats the other by $138,615,809.26/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DSKYF + KO for your $10,000?

DSKYF: 50%KO: 50%
100% KO50/50100% DSKYF
Portfolio after 10yr
$87.81M
Annual income
$81,543,015.11/yr
Blended yield
92.86%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on KO right now

DSKYF
No analyst data
Altman Z
3.4
Piotroski
6/9
KO
Analyst Ratings
29
Buy
16
Hold
3
Sell
Consensus: Buy
Price Target
$84.88
+11.3% upside vs current
Range: $81.00 — $88.00
Altman Z
5.0
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DSKYF buys
0
KO buys
0
No recent congressional trades found for DSKYF or KO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDSKYFKO
Forward yield2.50%2.70%
Annual dividend / share$0.46$2.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%24.3%
Portfolio after 10y$175.59M$34.1K
Annual income after 10y$163,081,726.45$4,303.79
Total dividends collected$174.63M$15.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: DSKYF vs KO ($10,000, DRIP)

YearDSKYF PortfolioDSKYF Income/yrKO PortfolioKO Income/yrGap
1← crossover$11,201$500.97$10,846$335.73+$355.00DSKYF
2$13,034$1,048.84$11,829$430.64+$1.2KDSKYF
3$16,228$2,281.26$12,988$555.50+$3.2KDSKYF
4$22,672$5,308.83$14,372$721.34+$8.3KDSKYF
5$38,123$13,863.99$16,049$944.01+$22.1KDSKYF
6$84,366$43,574.29$18,114$1,246.74+$66.3KDSKYF
7$270,513$180,241.39$20,702$1,664.24+$249.8KDSKYF
8$1,369,690$1,080,240.94$24,008$2,249.48+$1.35MDSKYF
9$11,689,092$10,223,523.95$28,317$3,085.19+$11.66MDSKYF
10$175,589,055$163,081,726.45$34,065$4,303.79+$175.55MDSKYF

DSKYF vs KO: Complete Analysis 2026

DSKYFStock

Daiichi Sankyo Company, Limited researches and develops, manufactures, imports, markets, and sells pharmaceutical products worldwide. The company offers trastuzumab deruxtecan, an anti-cancer agent and anti-HER2 antibody drug conjugate; mirogabalin for pain treatment; teneligliptin/canagliflozin for type 2 diabetes mellitus treatment; lacosamide anti-epileptic agent; prasugrel, an antiplatelet agent; denosumab for osteoporosis and bone disorders; teneligliptin for type 2 diabetes mellitus treatment; edoxaban, an anticoagulant; esomeprazole for ulcer treatment; memantine for treating Alzheimer's disease; and laninamivir for anti-influenza treatment. It also provides olmesartan, an antihypertensive agent; levofloxacin, an antibacterial agent; pravastatin for hypercholesterolemia treatment; and loxoprofen, an anti-inflammatory analgesic. In addition, the company offers colesevelam for treating hypercholesterolemia and type 2 diabetes mellitus treatment; and ferric carboxymaltose and iron sucrose injections for treating anemia. Further, it provides Lulu, a combination cold remedy; Loxonin S, an antipyretic analgesic /anti-inflammatory analgesic; Transino for melasma improvement and treating against spots and freckles; Minon, a skincare product; and Breath Labo and Clean Dental oral care products, as well as Silodosin for dysuria; Gefitinib for malignant tumours; Bicalutamide for prostate cancer; and Tamoxifen, an anti-breast cancer agent. Additionally, the company offers adsorbed cell culture-derived influenza, influenza HA, measles rubella combined, and mumps vaccines. It also provides pharmaceuticals and drugs for animals, cosmetics, medical equipment, food products, drinking water, active pharmaceutical ingredients, and intermediates. It has collaboration with Guardant Health to develop Guardant360 CDx as a companion diagnostic for Enhertu in advanced metastatic non-small cell lung cancer. The company was founded in 1899 and is headquartered in Tokyo, Japan.

Full DSKYF Calculator →

KOConsumer Staples

The Coca-Cola Company, a beverage company, manufactures, markets, and sells various nonalcoholic beverages worldwide. The company provides sparkling soft drinks, sparkling flavors; water, sports, coffee, and tea; juice, value-added dairy, and plant-based beverages; and other beverages. It also offers beverage concentrates and syrups, as well as fountain syrups to fountain retailers, such as restaurants and convenience stores. The company sells its products under the Coca-Cola, Diet Coke/Coca-Cola Light, Coca-Cola Zero Sugar, caffeine free Diet Coke, Cherry Coke, Fanta Orange, Fanta Zero Orange, Fanta Zero Sugar, Fanta Apple, Sprite, Sprite Zero Sugar, Simply Orange, Simply Apple, Simply Grapefruit, Fresca, Schweppes, Thums Up, Aquarius, Ayataka, BODYARMOR, Ciel, Costa, Dasani, dogadan, FUZE TEA, Georgia, glacéau smartwater, glacéau vitaminwater, Gold Peak, Ice Dew, I LOHAS, Powerade, Topo Chico, AdeS, Del Valle, fairlife, innocent, Minute Maid, and Minute Maid Pulpy brands. It operates through a network of independent bottling partners, distributors, wholesalers, and retailers, as well as through bottling and distribution operators. The company was founded in 1886 and is headquartered in Atlanta, Georgia.

Full KO Calculator →
📬

Get this DSKYF vs KO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DSKYF vs SCHDDSKYF vs JEPIDSKYF vs ODSKYF vs MAINDSKYF vs PEPDSKYF vs PGDSKYF vs JNJDSKYF vs MCD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.